Viewing StudyNCT06484985

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-07-17 @ 11:43 AM
Last Modification Date: 2024-10-26 @ 3:33 PM
Study NCT ID: NCT06484985
Status: RECRUITING
Last Update Posted: 2024-07-03
First Post: 2024-06-26
Brief Title: Study of AXT-1003 in Subjects With Advanced Malignant Tumors
Sponsor: Axter Therapeutics Beijing Co Ltd
Organization: Axter Therapeutics Beijing Co Ltd
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Non-Hodgkin Lymphoma
Advanced Solid Tumor
Keywords:
Name View
AXT-1003 View
EZH2 View
Phase I View
Advanced malignancies View